Kang Koo Jeong, Ahn Keun Soo
Koo Jeong Kang, Keun Soo Ahn, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, School of Medicine, Keimyung University Dong-san Medical Center, Daegu 41931, South Korea.
World J Gastroenterol. 2017 Feb 21;23(7):1139-1146. doi: 10.3748/wjg.v23.i7.1139.
Hepatocellular carcinoma (HCC) is the sixth most common type of cancer and the third most frequent cause of cancer-related death. Advances in preoperative assessment of HCC (., imaging studies and liver function tests), surgical techniques, and postoperative care have improved the surgical outcomes and survival of patients who undergo hepatic resection for HCC. However, in the last 20 years, the long-term survival after hepatectomy has remained unsatisfactory owing to the high rates of local recurrence and multicentric occurrence. Anatomical liver resection (AR) was introduced in the 1980s. Although several studies have revealed tangible benefits of AR for HCC, these benefits are still debated. Because most HCCs occur in patients with liver cirrhosis and poor hepatic function, there are many factors that affect survival, including the surgical method. Nevertheless, many studies have documented the perioperative and long-term benefits of AR in various conditions. In this article, we review the results of several recently published, well-designed comparative studies of AR, to investigate whether AR provides real benefits on survival outcomes. We also discuss the potential pitfalls associated with this approach.
肝细胞癌(HCC)是第六大常见癌症类型,也是癌症相关死亡的第三大常见原因。肝细胞癌术前评估(如影像学检查和肝功能测试)、手术技术及术后护理方面的进展,改善了接受肝癌肝切除术患者的手术效果及生存率。然而,在过去20年里,由于局部复发率和多中心发生率较高,肝切除术后的长期生存率仍不尽人意。解剖性肝切除术(AR)于20世纪80年代被引入。尽管多项研究揭示了AR对肝细胞癌的切实益处,但这些益处仍存在争议。由于大多数肝细胞癌发生于肝硬化和肝功能差的患者中,影响生存的因素众多,包括手术方法。尽管如此,许多研究记录了AR在各种情况下的围手术期及长期益处。在本文中,我们回顾了近期发表的几项设计良好的AR对比研究结果,以调查AR是否对生存结局具有实际益处。我们还讨论了与该方法相关的潜在陷阱。